NIFTY 50

Cash in books will be used for M&As, growth: Gland Pharma

Updated : November 20, 2020 15:42:08 IST

Hyderabad-based Gland Pharma on Friday said the cash in books will be used for merger and acquisitions (M&As) and growth after it made a strong debut on the exchanges today.

Speaking in an interview with CNBC-TV18, Srinivas Sadu, managing director, said, "We have a resilient business and launches are in the pipeline."

According to him, there are not many players in the business-to-business (B2B) injectable industry.

On growth, Sadu said, "Going forward, growth will be in line with last year's performance. The company is doing well in Africa, Brazil, and Canada and filing new products in all geographies."

For the entire interview, watch the video
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you